0.73
Finanzdaten der Akari Therapeutics Plc Adr-Aktie (AKTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
|
3.525
|
- | - | - | - |
Operating Income/Loss |
33.21%
-3.525
|
-5.278 | -2.927 | -7.449 | -5.989 |
Nonoperating Income/Loss |
111.95%
-0.18
|
1.506 | 0.032 | -0.109 | 0.423 |
Income/Loss From Continuing Operations Before Tax |
1.78%
-3.705
|
-3.772 | -2.895 | -7.558 | -5.566 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
1.78%
-3.705
|
-3.772 | -2.895 | -7.558 | -5.566 |
|
1.78%
-3.705
|
-3.772 | -2.895 | -7.558 | -5.566 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
997.01%
54,588.28
|
4,976.08 | 24,386.01 | 18,836.48 | 13,453.15 |
Diluted Average Shares |
997.01%
54,588.28
|
4,976.08 | 24,386.01 | 18,836.48 | 13,453.15 |
Basic Earnings Per Share |
-
|
- | - | - | - |
Diluted Earnings Per Share |
-
|
- | - | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):